NUMA1 and bladder transitional cell carcinoma: Moreover, nuclear matrix protein-22 (NMP-22), bladder tumor antigen (BTA), BTAstat and BTA-TRAK, UroVysion in Fluorescence in situ Hybridization, urine miRNA and urine cell-free DNA show high clinical application value for the diagnosis of BLCA.